Crossmark

MEDREV (pharmacy-health psychology intervention in people living with dementia with behaviour that challenges): the feasibility of measuring clinical outcomes and costs of the intervention

Crossref DOI link: https://doi.org/10.1186/s12913-020-5014-0

Published Online: 2020-03-02

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maidment, Ian D. http://orcid.org/0000-0003-4152-9704
Barton, Garry

Campbell, Niyah

Shaw, Rachel

Seare, Nichola

Fox, Chris

Iliffe, Steve

Randle, Emma

Hilton, Andrea

Brown, Graeme

Barnes, Nigel

Wilcock, Jane

Gillespie, Sarah

Damery, Sarah
Funding

Funding for this research was provided by:

Research for Patient Benefit Programme (PB-PG-0613-31071)
License Information

Text and Data Mining valid from 2020-03-02

Version of Record valid from 2020-03-02
More Information

Article History

Received: 29 May 2019

Accepted: 20 February 2020

First Online: 2 March 2020

Ethics approval and consent to participate

: The study received ethical approval from National Research Ethics Services (15/EM/0314) Committee East Midlands - Nottingham 1. Written consent/assent was obtained from the participant, or their personal consultee, as appropriate in line with the Mental Capacity Act, 2005. The sponsor and ethics (equivalent of the IRB) explicitly approved this procedure for the collection of consent in the case of consent obtained from the personal consultee’s of participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below